Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04011592

Organisation Name: The University of Texas Health Science Center, Houston

Overal Status: Terminated

Start Date: March 4, 2019

Last Update: September 14, 2020

Lead Sponsor: The University of Texas Health Science Center, Houston

Brief Summary: Postpartum depression is a non-psychotic major or minor depressive episode that occurs during pregnancy or within 12 months of post-partum period. The nature of symptoms is same as depressive episode characterized by depressed mood, anxiety, sleep difficulties, suicidal thoughts, tiredness and diminished interest in pleasurable activities. Severe maternal depression affects children by increasing the risk of emotional and behavioral and physical health problems and cognitive difficulties. Thus early screening and intervention is critical in reducing the negative impact of PND in the mother and child, family and the community.

The purpose of this study is to assess the safety, pharmacokinetics and antidepressant efficacy of sub-anesthetic dose of intravenous ketamine in perinatal depression.

Conditions:
  • Post Partum Depression


Total execution time in seconds: 0.18121695518494